Logo

Tonix Pharmaceuticals: Jeffrey Rosenfeld

Mar 09, 2022

Jeffrey Rosenfeld has been appointed as executive director of genomics and bioinformatics at Tonix Pharmaceuticals. He will direct the company's pharmacogenomics efforts, including the use of artificial intelligence, genome-wide association studies, and mathematical modeling to analyze patient outcomes in Tonix clinical trials. Rosenfeld joins the firm from the Rutgers Cancer Institute of New Jersey, where he was an assistant professor of pathology and laboratory medicine and manager of the biomedical informatics shared resource. He hold a BS in biology and an MS in biotechnology from the University of Pennsylvania and a PhD in biology from New York University.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.